Biosino Bio-Technology & Science Inc ($8247) - buy or sell? Stock discussion, ideas, forum

Biosino Bio-Technology & Science Inc

Biosino Bio-Technology & Science, Inc.

Industry: Healthcare-Products

Ticker	Exchange	ISIN	Name
$8247	HKEx GEM	CNE100000288	Code: 8247

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 8247 stock

Share your investment idea or question on Biosino Bio-Technology & Science Inc stock:

Latest twits on Biosino Bio-Technology & Science Inc (8247)

No twits yet. Be the first to post!

Have a question about 8247? Ask and other investors will be eager to help you.

Have an idea about 8247? Share it with other investors.

Biosino Bio-Technology & Science Inc news

18/03/2017 Biosino Bio-Technology & Science Inc revenue jumped on 12.1%

18/03/2016 Biosino Bio-Technology & Science Inc EBITDA dropped on 35.0% in 2015 and EBITDA Margin decreased on 5.4 pp from 13.4% to 7.9%

Biosino Bio-Technology & Science Inc stock price chart

Biosino Bio-Technology & Science Inc financials

mln. CNY	FY2010	FY2011	FY2012

Revenue	168.4	184.2	210.1
EBITDA	48.568	46.117	38.377
Net income	27.647	17.956	17.242
CAPEX	9.464	40.489	26.561
Debt	19.801	30.000	0.000
Cash	161.7	92.146	43.156

Biosino Bio-Technology & Science Inc news

About Biosino Bio-Technology & Science Inc

Biosino Bio-Technology & Science, Inc. is a biotechnology company. The Company develops, manufactures, and markets protein-based in-vitro diagnostic reagents and biochemical drugs. The Company's diagnostic reagents help diagnose cardiac, helatic, diabetes, inflammation/immunology, and pancreatic related diseases.